CRL vs. AKO-A
CRL (Charles River Laboratories International, Inc.) and AKO-A (Embotelladora Andina S.A) are both stocks. CRL operates in Diagnostics & Research (Healthcare), while AKO-A operates in Beverages - Non-Alcoholic (Consumer Defensive). Over the past 10 years, CRL returned 8.21%/yr vs 8.38%/yr for AKO-A. At a 0.08 correlation, their price movements are largely independent.
Performance
CRL vs. AKO-A - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CRL achieves a -6.54% return, which is significantly higher than AKO-A's -10.20% return. Both investments have delivered pretty close results over the past 10 years, with CRL having a 8.21% annualized return and AKO-A not far ahead at 8.38%.
CRL
- 1D
- 2.81%
- 1M
- 4.97%
- YTD
- -6.54%
- 6M
- -0.36%
- 1Y
- 28.85%
- 3Y*
- -1.93%
- 5Y*
- -11.63%
- 10Y*
- 8.21%
AKO-A
- 1D
- -11.01%
- 1M
- -7.42%
- YTD
- -10.20%
- 6M
- -8.49%
- 1Y
- 4.96%
- 3Y*
- 25.94%
- 5Y*
- 21.94%
- 10Y*
- 8.38%
CRL vs. AKO-A - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
CRL Charles River Laboratories International, Inc. | -6.54% | 8.06% | -21.91% | 8.49% | -42.17% | 50.80% | 63.56% | 34.97% | 3.41% | 43.65% |
AKO-A Embotelladora Andina S.A | -10.20% | 69.94% | 22.39% | 32.28% | 25.25% | -15.56% | -9.03% | -14.12% | -25.96% | 33.08% |
Correlation
The correlation between CRL and AKO-A is 0.01, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.01 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.03 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.04 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.06 |
Correlation (All Time) Calculated using the full available price history since Jun 26, 2000 | 0.08 |
Fundamentals
CRL:
$9.13B
AKO-A:
$3.06B
CRL:
-$3.75
AKO-A:
$1.95K
CRL:
2.28
AKO-A:
0.00
CRL:
3.10
AKO-A:
0.00
CRL:
$4.03B
AKO-A:
$3.42T
CRL:
$1.00B
AKO-A:
$1.34T
CRL:
$737.05M
AKO-A:
$620.88B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CRL vs. AKO-A — Risk / Return Rank
CRL
AKO-A
CRL vs. AKO-A - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Charles River Laboratories International, Inc. (CRL) and Embotelladora Andina S.A (AKO-A). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| CRL | AKO-A | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.55 | ||
| Sortino ratioReturn per unit of downside risk | +0.62 | ||
| Omega ratioGain probability vs. loss probability | 1.15 | 1.08 | +0.07 |
| Calmar ratioReturn relative to maximum drawdown | 0.86 | 0.22 | +0.63 |
| Martin ratioReturn relative to average drawdown | 1.77 | 0.55 | +1.22 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| CRL | AKO-A | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.64 | 0.10 | +0.55 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.27 | 0.52 | -0.79 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.22 | 0.20 | +0.02 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.24 | 0.20 | +0.04 |
Drawdowns
CRL vs. AKO-A - Drawdown Comparison
The maximum CRL drawdown since its inception was -78.23%, roughly equal to the maximum AKO-A drawdown of -79.18%. Use the drawdown chart below to compare losses from any high point for CRL and AKO-A.
Loading charts...
Drawdown Indicators
| CRL | AKO-A | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -78.23% | -79.18% | +0.95% |
Max Drawdown (1Y)Largest decline over 1 year | -33.88% | -22.40% | -11.48% |
Max Drawdown (3Y)Largest decline over 3 years | -63.52% | -25.41% | -38.11% |
Max Drawdown (5Y)Largest decline over 5 years | -78.23% | -25.41% | -52.82% |
Max Drawdown (10Y)Largest decline over 10 years | -78.23% | -63.51% | -14.72% |
Current DrawdownCurrent decline from peak | -59.32% | -22.40% | -36.92% |
Average DrawdownAverage peak-to-trough decline | -25.73% | -30.92% | +5.19% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 16.36% | 9.07% | +7.29% |
Volatility
CRL vs. AKO-A - Volatility Comparison
Charles River Laboratories International, Inc. (CRL) and Embotelladora Andina S.A (AKO-A) have volatilities of 16.68% and 16.27%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CRL | AKO-A | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 16.68% | 16.27% | +0.41% |
Volatility (6M)Calculated over the trailing 6-month period | 34.88% | 41.68% | -6.80% |
Volatility (1Y)Calculated over the trailing 1-year period | 45.06% | 52.00% | -6.94% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 42.76% | 42.35% | +0.41% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 37.78% | 41.97% | -4.19% |
Dividends
CRL vs. AKO-A - Dividend Comparison
CRL has not paid dividends to shareholders, while AKO-A's dividend yield for the trailing twelve months is around 5.09%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
AKO-A Embotelladora Andina S.A | 5.09% | 5.24% | 6.95% | 9.27% | 17.81% | 8.12% | 5.74% | 4.72% | 4.16% | 2.63% | 2.34% | 2.50% |
CRL Charles River Laboratories International, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
CRL vs. AKO-A - Financials Comparison
This section allows you to compare key financial metrics between Charles River Laboratories International, Inc. and Embotelladora Andina S.A. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
CRL vs. AKO-A - Profitability Comparison
CRL - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Charles River Laboratories International, Inc. reported a gross profit of 0.00 and revenue of 995.83M. Therefore, the gross margin over that period was 0.0%.
AKO-A - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Embotelladora Andina S.A reported a gross profit of 393.07B and revenue of 958.49B. Therefore, the gross margin over that period was 41.0%.
CRL - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Charles River Laboratories International, Inc. reported an operating income of 119.90M and revenue of 995.83M, resulting in an operating margin of 12.0%.
AKO-A - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Embotelladora Andina S.A reported an operating income of 147.46B and revenue of 958.49B, resulting in an operating margin of 15.4%.
CRL - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Charles River Laboratories International, Inc. reported a net income of -14.84M and revenue of 995.83M, resulting in a net margin of -1.5%.
AKO-A - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Embotelladora Andina S.A reported a net income of 102.93B and revenue of 958.49B, resulting in a net margin of 10.7%.
Frequently Asked Questions
CRL and AKO-A have a correlation of 0.01, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
CRL has higher volatility (16.68%) compared to AKO-A (16.27%). In terms of maximum drawdown, CRL dropped -78.23% vs AKO-A's -79.18%.
CRL currently has the higher Sharpe Ratio (0.64 vs 0.10), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for CRL and AKO-A
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer